138 related articles for article (PubMed ID: 1697897)
1. Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia.
Perry EK; Marshall E; Kerwin J; Smith CJ; Jabeen S; Cheng AV; Perry RH
J Neurochem; 1990 Oct; 55(4):1454-6. PubMed ID: 1697897
[TBL] [Abstract][Full Text] [Related]
2. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease.
Perry EK; McKeith I; Thompson P; Marshall E; Kerwin J; Jabeen S; Edwardson JA; Ince P; Blessed G; Irving D
Ann N Y Acad Sci; 1991; 640():197-202. PubMed ID: 1723256
[TBL] [Abstract][Full Text] [Related]
3. Cholinergic and dopaminergic activities in senile dementia of Lewy body type.
Perry EK; Marshall E; Perry RH; Irving D; Smith CJ; Blessed G; Fairbairn AF
Alzheimer Dis Assoc Disord; 1990; 4(2):87-95. PubMed ID: 2357341
[TBL] [Abstract][Full Text] [Related]
4. Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases.
Cheng AV; Ferrier IN; Morris CM; Jabeen S; Sahgal A; McKeith IG; Edwardson JA; Perry RH; Perry EK
J Neurol Sci; 1991 Nov; 106(1):50-5. PubMed ID: 1779239
[TBL] [Abstract][Full Text] [Related]
5. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
Davies P
Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427
[No Abstract] [Full Text] [Related]
6. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.
Perry EK; Smith CJ; Court JA; Perry RH
J Neural Transm Park Dis Dement Sect; 1990; 2(3):149-58. PubMed ID: 2175197
[TBL] [Abstract][Full Text] [Related]
7. Visual hallucinations are associated with lower alpha bungarotoxin binding in dementia with Lewy bodies.
Court JA; Ballard CG; Piggott MA; Johnson M; O'Brien JT; Holmes C; Cairns N; Lantos P; Perry RH; Jaros E; Perry EK
Pharmacol Biochem Behav; 2001 Dec; 70(4):571-9. PubMed ID: 11796155
[TBL] [Abstract][Full Text] [Related]
8. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.
Crow TJ; Cross AJ; Cooper SJ; Deakin JF; Ferrier IN; Johnson JA; Joseph MH; Owen F; Poulter M; Lofthouse R
Neuropharmacology; 1984 Dec; 23(12B):1561-9. PubMed ID: 6084823
[TBL] [Abstract][Full Text] [Related]
9. A juvenile case of frontotemporal dementia: neurochemical and neuropathological investigations.
Nagaoka S; Arai H; Iwamoto N; Ohwada J; Ichimiya Y; Nakamura M; Inoue R
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1251-61. PubMed ID: 8868207
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease.
Perry EK; Irving D; Kerwin JM; McKeith IG; Thompson P; Collerton D; Fairbairn AF; Ince PG; Morris CM; Cheng AV
Alzheimer Dis Assoc Disord; 1993; 7(2):69-79. PubMed ID: 8347330
[TBL] [Abstract][Full Text] [Related]
11. Depletion of choline acetyltransferase activity but preservation of M1 and M2 muscarinic receptor binding sites in temporal cortex following head injury: a preliminary human postmortem study.
Dewar D; Graham DI
J Neurotrauma; 1996 Apr; 13(4):181-7. PubMed ID: 8860198
[TBL] [Abstract][Full Text] [Related]
12. The cholinergic system in old age and Alzheimer's disease.
Perry EK
Age Ageing; 1980 Feb; 9(1):1-8. PubMed ID: 7361631
[TBL] [Abstract][Full Text] [Related]
13. Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy.
Bowen DM; Procter AW; Mann DM; Snowden JS; Esiri MM; Neary D; Francis PT
Psychopharmacology (Berl); 2008 Mar; 196(4):603-10. PubMed ID: 18026720
[TBL] [Abstract][Full Text] [Related]
14. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.
Harding AJ; Broe GA; Halliday GM
Brain; 2002 Feb; 125(Pt 2):391-403. PubMed ID: 11844739
[TBL] [Abstract][Full Text] [Related]
15. Delusions associated with elevated muscarinic binding in dementia with Lewy bodies.
Ballard C; Piggott M; Johnson M; Cairns N; Perry R; McKeith I; Jaros E; O'Brien J; Holmes C; Perry E
Ann Neurol; 2000 Dec; 48(6):868-76. PubMed ID: 11117543
[TBL] [Abstract][Full Text] [Related]
16. Neurotransmitters in the brains of patients with dementia disorders.
Gottfries CG
Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668
[No Abstract] [Full Text] [Related]
17. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
Kellar KJ; Whitehouse PJ; Martino-Barrows AM; Marcus K; Price DL
Brain Res; 1987 Dec; 436(1):62-8. PubMed ID: 3690354
[TBL] [Abstract][Full Text] [Related]
18. Nature and mechanisms of cholinergic-monoaminergic interactions in the brain.
Butcher LL
Life Sci; 1977 Nov; 21(9):1207-26. PubMed ID: 337018
[No Abstract] [Full Text] [Related]
19. Neurochemical features of frontotemporal dementia.
Procter AW; Qurne M; Francis PT
Dement Geriatr Cogn Disord; 1999; 10 Suppl 1():80-4. PubMed ID: 10436347
[TBL] [Abstract][Full Text] [Related]
20. Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
Palmer AM; Wilcock GK; Esiri MM; Francis PT; Bowen DM
Brain Res; 1987 Jan; 401(2):231-8. PubMed ID: 2434191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
